Breaking News

Tweet TWEET

Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery

PR Newswire/Les Echos/ 
Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery 
INDIANAPOLIS, May 7, 2013 -- Eli Lilly and Company (NYSE:LLY) today announced
that John C. Lechleiter, Ph.D., chairman, president, and chief executive
officer, will undergo scheduled surgery for a dilated aorta on Monday, May 13,
2013. This condition was found during unrelated testing and has been
asymptomatic. Lechleiter is expected to make a full recovery and return to his
duties later this summer. 
In accordance with the company's bylaws, Derica W. Rice, executive vice
president, Global Services and chief financial officer, will assume the
additional role of acting chief executive officer during Lechleiter's surgery
and recuperation period. Ellen R. Marram, currently the board's lead 
independent director, will serve as acting chairperson of the board of 
directors. She was appointed as lead independent director in April 2012. 
Rice, 48, has more than 22 years of service with Eli Lilly and Company,
including leadership roles in finance and general management. He became chief
financial officer in 2006 and assumed leadership of the company's global
services organization in 2010. 
Marram, 66, is president of the Barnegat Group LLC, her business advisory firm,
and she is also the former CEO of two consumer products companies. She has
served on the Lilly board since 2002 and is also a member of the board of
directors of Ford Motor Company and The New York Times Company. 
"I am grateful to be under the care of a world-class medical team located right
here in Indianapolis," said Lechleiter. "The board of directors and I have the
utmost confidence in Ellen, Derica, and our Lilly leadership team. The company
will be in very good hands during my leave. I look forward to returning to work
following my recovery." 
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -
through medicines and information - for some of the world's most urgent medical
needs. Additional information about Lilly is available at www.lilly.com. C-LLY 
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)  
Refer to: (317) 433-9899, egs@lilly.com - Edward Sagebiel
 

SOURCE Eli Lilly and Company 
                  
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- May/08/2013 10:17 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.